English  |  正體中文  |  简体中文  |  2831143  
???header.visitor??? :  33150952    ???header.onlineuser??? :  1007
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"wu s g"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 76-100 of 224  (9 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2020-12-02T02:33:59Z Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR Chung K.-P.; Wu S.-G.; Wu J.-Y.; Yang J.-H.; Yu C.-J.; Wei P.-F.; Shih J.-Y.; Pan-Chyr Yang; Chung K.-P.; Wu S.-G.; Wu J.-Y.; Yang J.-H.; Yu C.-J.; Wei P.-F.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:33:52Z Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis Wu S.-G.; Hu F.-C.; Chang Y.-L.; Lee Y.-C.; Yu C.-J.; Chang Y.-C.; Wu J.-Y.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:33:49Z Survival of lung adenocarcinoma patients with malignant pleural effusion Wu S.-G.; Yu C.-J.; Tsai M.-F.; Liao W.-Y.; Yang C.-H.; Jan I.-S.; PAN-CHYR YANG; Shih J.-Y.; Wu S.-G.; Yu C.-J.; Tsai M.-F.; Liao W.-Y.; Yang C.-H.; Jan I.-S.; PAN-CHYR YANG; Shih J.-Y.
臺大學術典藏 2020-12-02T02:33:45Z Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations Chen Y.-F.;Hsieh M.-S.;Wu S.-G.;Chang Y.-L.;Shih J.-Y.;Liu Y.-N.;Tsai M.-F.;Tsai T.-H.;Yu C.-J.;Yang J.C.-H.;PAN-CHYR YANG; Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; Shih J.-Y.; Liu Y.-N.; Tsai M.-F.; Tsai T.-H.; Yu C.-J.; Yang J.C.-H.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:33:39Z Development of renal cysts after crizotinib treatment in advanced ALK-positive non-small-cell lung cancer Lin Y.-T.;Wang Y.-F.;Yang J.C.-H.;Yu C.-J.;Wu S.-G.;Shih J.-Y.;Pan-Chyr Yang; Lin Y.-T.; Wang Y.-F.; Yang J.C.-H.; Yu C.-J.; Wu S.-G.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:33:29Z EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway Tsai M.-F.; Chang T.-H.; Wu S.-G.; Yang H.-Y.; Hsu Y.-C.; Pan-Chyr Yang; Shih J.-Y.; Tsai M.-F.; Chang T.-H.; Wu S.-G.; Yang H.-Y.; Hsu Y.-C.; PAN-CHYR YANG; Shih J.-Y.
臺大學術典藏 2020-12-02T02:33:26Z Efficacy of pemetrexed-based chemotherapy in patients with ROS1 fusion-positive lung adenocarcinoma compared with in patients harboring other driver mutations in East Asian populations Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; Yu C.-J.; Yang J.C.-H.; Pan-Chyr Yang; Shih J.-Y.; Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; Yu C.-J.; Yang J.C.-H.; PAN-CHYR YANG; Shih J.-Y.
臺大學術典藏 2020-12-02T02:33:23Z The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients Wu S-G.; Liu Y.-N.; Tsai M.-F.; Chang Y.-L.; Yu C.-J.; Pan-Chyr Yang; Yang J.C.-H.; Wen Y.-F.; Shih J.-Y.; Wu S-G.; Liu Y.-N.; Tsai M.-F.; Chang Y.-L.; Yu C.-J.; PAN-CHYR YANG; Yang J.C.-H.; Wen Y.-F.; Shih J.-Y.
臺大學術典藏 2020-12-02T02:33:21Z Association of BIM deletion polymorphism with intrinsic resistance to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma Shih J.-Y.; Wu S.-G.; Liu Y.-N.; Yu C.-J.; Pan-Chyr Yang; Shih J.-Y.; Wu S.-G.; Liu Y.-N.; Yu C.-J.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:33:19Z The role of PIK3CA mutations among lung adenocarcinoma patients with primary and acquired resistance to EGFR tyrosine kinase inhibition Wu S.-G.; Chang Y.-L.; Yu C.-J.; Pan-Chyr Yang; Shih J.-Y.; Wu S.-G.; Chang Y.-L.; Yu C.-J.; PAN-CHYR YANG; Shih J.-Y.
臺大學術典藏 2020-12-02T02:33:14Z Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C Chang T.-H.; PAN-CHYR YANG et al.; Chang T.-H.; Tsai M.-F.; Gow C.-H.; Wu S.-G.; Liu Y.-N.; Chang Y.-L.; Yu S.-L.; Tsai H.-C.; Lin S.-W.; Chen Y.-W.; Kuo P.-Y.; Pan-Chyr Yang; Shih J.-Y.
臺大學術典藏 2020-08-18T07:28:24Z Development of renal cysts after crizotinib treatment in advanced ALK-positive non-small-cell lung cancer Yang J.C.-H.; YU-FEN WANG; Lin Y.-T.; Yu C.-J.; Wu S.-G.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2020-08-13T06:34:00Z First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer Wu J.-Y.; Yu C.-J.; Yang P.-C.; JIN-YUAN SHIH; Wei P.-F.; Hsu Y.-C.; Chang Y.-C.; Gow C.-H.; Yang C.-H.; Wu S.-G.; Chiu Y.-H.
臺大學術典藏 2020-08-13T06:34:00Z Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma Wu S.-G.; Gow C.-H.; Yu C.-J.; Chang Y.-L.; Yang C.-H.; Hsu Y.-C.; JIN-YUAN SHIH; Lee Y.-C.; Yang P.-C.
臺大學術典藏 2020-08-13T06:33:56Z Good response to gefitinib in lung adenocarcinoma harboring coexisting EML4-ALK fusion gene and EGFR mutation Kuo Y.-W.;Wu S.-G.;Ho C.-C.;Jin-Yuan Shih; Kuo Y.-W.; Wu S.-G.; Ho C.-C.; JIN-YUAN SHIH
臺大學術典藏 2020-08-13T06:33:54Z Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor Lin S.-B.; Wu C.-P.; JIN-YUAN SHIH; Yang P.-C.; Lan C.-C.; Yang C.-H.; Yu Y.-L.; Yu S.-L.; Huang C.-P.; Chang T.-H.; Tsai M.-F.; Su K.-Y.; Wu S.-G.
臺大學術典藏 2020-08-13T06:33:53Z Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations Chang Y.-L.; JIN-YUAN SHIH; Yang P.-C.; Hsu Y.-C.; Lee J.-H.; Wu S.-G.;Yang C.-H.;Yu C.-J.;Lee J.-H.;Hsu Y.-C.;Chang Y.-L.;Jin-Yuan Shih;Yang P.-C.; Wu S.-G.; Yang C.-H.; Yu C.-J.
臺大學術典藏 2020-08-13T06:33:53Z Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations Wu J.-Y.; Wu S.-G.; Yang C.-H.; Chang Y.-L.; Chang Y.-C.; Hsu Y.-C.; JIN-YUAN SHIH; Yang P.-C.
臺大學術典藏 2020-08-13T06:33:52Z Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction Lee Y.-C.; Tsai M.-F.; Wu S.-G.; Chang Y.-L.; Lin J.-W.; Wu C.-T.; Chen H.-Y.; Yu C.-J.; JIN-YUAN SHIH
臺大學術典藏 2020-08-13T06:33:50Z EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with Wild-type EGFR Tsai M.-F.; Yu C.-J.; Chen Y.-H.; JIN-YUAN SHIH; Chang Y.-L.; Kuo Y.-W.; Wu S.-G.; Wu S.-G.;Kuo Y.-W.;Chang Y.-L.;Jin-Yuan Shih;Chen Y.-H.;Tsai M.-F.;Yu C.-J.;Yang C.-H.;Yang P.-C.; Yang C.-H.; Yang P.-C.
臺大學術典藏 2020-08-13T06:33:50Z Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma JIN-YUAN SHIH; Tsai T.-H.; Wu S.-G.; Chang Y.-L.; Wu C.-T.; Tsai M.-F.; Wei P.-F.; Yang C.-H.; Yu C.-J.; Yang P.-C.
臺大學術典藏 2020-08-13T06:33:47Z Survival of lung adenocarcinoma patients with malignant pleural effusion Wu S.-G.; Yu C.-J.; Tsai M.-F.; Liao W.-Y.; Yang C.-H.; Jan I.-S.; Yang P.-C.; JIN-YUAN SHIH
臺大學術典藏 2020-08-13T06:33:46Z Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; JIN-YUAN SHIH; Liu Y.-N.; Tsai M.-F.; Tsai T.-H.; Yu C.-J.; Yang J.C.-H.; Yang P.-C.
臺大學術典藏 2020-08-13T06:33:46Z Phosphorylated insulin-like growth factor-1 receptor (pIGF1R) is a poor prognostic factor in brain metastases from lung adenocarcinomas Lin C.-H.; Cheng A.-L.; Wu S.-G.; JIN-YUAN SHIH; Wu P.-F.; Huang W.-C.; Yang J.C.-H.; Lu Y.-S.
臺大學術典藏 2020-08-13T06:33:45Z Brain Metastasis of Patients with Lung Adenocarcinoma: Epidermal Growth Factor Receptor Mutations and Response to Whole-Brain Radiation Therapy Wu S.-G.; JIN-YUAN SHIH

Showing items 76-100 of 224  (9 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 > >>
View [10|25|50] records per page